Portfolio of Medical Laboratory and Research Stocks Working on Coronavirus Testing
Here are 11 medical laboratory and research companies working on tests to detect the coronavirus.
11 Medical Laboratory and Research Stocks | ||
---|---|---|
Name | Symbol | Recent Prices |
Abbott Laboratories | ABT | |
Aytu BioScience | AYTU | |
Co-Diagnostics | CODX | |
GenMark Diagnostics | GNMK | |
Hologic, | HOLX | |
Laboratory Corp. of America | LH | |
QIAGEN N.V. | QGEN | |
Quest Diagnostics | DGX | |
Quidel | QDEL | |
Roche Holding AG | RHHBY | |
Thermo Fisher Scientific | TMO | |
Price charts from Alpha Vantage as of most recent close. |
Portfolio Values
To inspect the performance of the Medical Laboratory and Research Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 9 stocks included in the portfolio computations are: ABT, GNMK, HOLX, LH, QGEN, DGX, QDEL, RHHBY and TMO. The current value of the portfolio assumes that $1,111.11 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. AYTU and CODX were excluded from the portfolio computations because of insufficient price data.
The current value of a $10,000 investment is $35,676. The percent return is 256.76%. The annualized return is 28.97%.
Portfolio Value Chart for Last 100 Daily Closes
Values of User-Selected Sample Portfolios: Discover the Most and Least Profitable Sample Portfolios
Related Portfolios
Portfolio of Digital Health Care Stocks
Portfolio of Medical Laboratory and Research Stocks
Portfolio of Medical Device Maker Stocks
Portfolio of Medical Equipment Stocks